Pfizer (PFE) Company Description

EXPIRED Pfizer GENERIC INITIATING ACU CHERICAL COMPOSETION EATING NEM CIENICAL S0015 Pfizer Sector: Health Care Industry: Pharmaceuticals Sub-Industry: Pharmaceuticals Ticker: PFE Fiscal Year: December 31 Company Overview Pfizer is a research-based pharmaceutical company that manufactures and markets medicines. It is a global leader in human pharmaceuticals, with reve- nues of $58.9 billion in 2012. Market Capitalization = $207.69bn as of /5/19 Revenues (2012) = $58.9bn Revenue CAGR* (four years through 2012) = 4.6% Net Income (2012) = $14.57bn *Compound Annual Growth Rate History of the Company Pfizer was founded by Charles Pfizer and Charles Earhart in New York City in 1849. The company's first blockbuster drug was Terramycin, an antibiotic used to treat infections, which it introduced in 1950. Pfizer has introduced many blockbuster drugs since then, among which Lipitor - a drug that lowers blood cholesterol - has been the most profitable. Geographical Revenue Breakdown 39% 23% 20% 18% United States Emerging Markets Europe Rest of the World Business Segments Contribution by Segment to Total Sales in 2012 Established Products and Emerging Specialty Care Primary Care and Oncology Animal Consumer Markets Healthcare Healthcare 34% 27% 26% 7% 6% Drug classes include: pain management, nutritionals, respiratory and gi-topicals, and over-the-counter drugs. Established Products: Provides drugs that have lost their exclusivity. Emerging Markets: Deals with operations in BRICS Famous brands include countries etc. Anadin, Centrum, Chapstick, ThermaCare, Imedeen, Robitussin and Preparation-H. Produces drugs with applications in cardiovascular diseases, sexual health, smoking cessation, and urology. Deals in prevention and disease treatment in livestock and companion animals. Drug classes include: vaccines, ophthalmic, surgical, inflammation, hemophilia, endocrine, pulmonary vascular, transplant and infectious diseases. Also provides all cancer-related drugs. Various clinical trials are being conducted for drugs used in the treatment of lung, prostate, colorectal, breast, liver and kidney cancer Provides anti-infectives, vaccines, parasiticides and medicinal feed additives. Discontinued operations in June 24, 2013. SOURCES: BIDNESS Company Data, SEC filings, Bloomberg Professional Services etc. DISCLAIMER: Bidness Etc(TM) and related marks are owned by Bidness Etc. Any other trademarks appearing on this website are the property of their respective owners, and are not used to indicate the origin of goods or services offered or provided by Bidness Etc herein or to suggest approval for or affiliation with Bidness Etc.